Ocular Therapeutix Inc (OCUL)
8.74
+0.22
(+2.58%)
USD |
NASDAQ |
Nov 22, 14:36
Ocular Therapeutix Total Assets (Quarterly): 490.37M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 490.37M |
| June 30, 2024 | 517.09M |
| March 31, 2024 | 538.95M |
| December 31, 2023 | 252.06M |
| September 30, 2023 | 162.38M |
| June 30, 2023 | 122.56M |
| March 31, 2023 | 128.57M |
| December 31, 2022 | 149.29M |
| September 30, 2022 | 158.58M |
| June 30, 2022 | 173.07M |
| March 31, 2022 | 187.62M |
| December 31, 2021 | 204.89M |
| September 30, 2021 | 217.74M |
| June 30, 2021 | 230.71M |
| March 31, 2021 | 243.04M |
| December 31, 2020 | 261.86M |
| September 30, 2020 | 98.22M |
| June 30, 2020 | 107.26M |
| March 31, 2020 | 72.86M |
| December 31, 2019 | 78.74M |
| September 30, 2019 | 88.71M |
| June 30, 2019 | 89.74M |
| Date | Value |
|---|---|
| March 31, 2019 | 101.49M |
| December 31, 2018 | 73.04M |
| September 30, 2018 | 70.27M |
| June 30, 2018 | 70.46M |
| March 31, 2018 | 76.68M |
| December 31, 2017 | 55.43M |
| September 30, 2017 | 64.40M |
| June 30, 2017 | 79.68M |
| March 31, 2017 | 90.70M |
| December 31, 2016 | 74.94M |
| September 30, 2016 | 82.35M |
| June 30, 2016 | 89.90M |
| March 31, 2016 | 100.43M |
| December 31, 2015 | 110.31M |
| September 30, 2015 | 119.32M |
| June 30, 2015 | 129.47M |
| March 31, 2015 | 71.50M |
| December 31, 2014 | 78.19M |
| September 30, 2014 | 83.88M |
| June 30, 2014 | 23.97M |
| March 31, 2014 | 15.08M |
| December 31, 2013 | 19.15M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
72.86M
Minimum
Mar 2020
538.95M
Maximum
Mar 2024
219.79M
Average
180.35M
Median
Total Assets (Quarterly) Benchmarks
| 4D Molecular Therapeutics Inc | 604.03M |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
| Theriva Biologics Inc | 40.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 138.35M |
| Shareholders Equity (Quarterly) | 352.02M |
| Debt to Equity Ratio | 0.1926 |
| Current Ratio | 13.01 |
| Net Debt Paydown Yield | -0.18% |